"Global Demand Outlook for Executive Summary Global Antibody Drug Conjugates Market Size and Share Introduction Antibody Drug Conjugates (ADCs) are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. Often described as ""biological missiles,"" ADCs consist of a monoclonal antibody chemically linked to a potent cell-killing drug. Unlike traditional...

Europe is also contributing significantly to market expansion with strong support for biotechnology research and innovation. Government funding and collaborations with universities are accelerating drug development. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering a strong CAGR of...